RM
Insider
Richard J Mark
DirectorRichard J Mark (Director) filed 2 Form 4 reports in the trailing twelve months (1 purchase, 1 sale), most often in DBA Sempra (SRE). Across 1 priced purchase filing, the average 21-session return was +8.3% from execution and +8.3% from disclosure (delay-adjusted; derived). The largest single filing was $2.6M of THC (10,000 sh × $263.42, as filed), executed Sep 10.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+8.3%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+8.3%
same 1 filings, from disclosure
Filings, ttm
2
1 buys · 1 sells
Median delay
0d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.9M
shares × price, as filed
Last traded
Sep 10
Filed Sep 14
Median ADV $308.5M across their filed names
Open performance→Volume by month
Buys $751K
Sells $2.6M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Utilities
1 filing
Sector per market data · by filing · past 12 months
Most traded names
SRE
DBA Sempra
SRE · 2 buys · 0 sells
2 filings
THCRecent filings
THCSALE
Tenet Healthcare Corporation
View filing →
$2.6M10,000 sh × $263.42
Exec Sep 10
Filed Sep 14 · 8:00 PM ET SREPURCHASE DBA Sempra View filing → $251K
2,692 sh × $93.30
Exec Mar 11
Filed Mar 11 · 7:19 PM ET SREPURCHASE DBA Sempra View filing → $500K
7,160 sh × $69.81
Exec Mar 6 2025
Filed Mar 7 2025 · 5:30 PM ET